Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.
about
Clinical predictor of survival following docetaxel-based chemotherapy.Exponential rise in prostate-specific antigen (PSA) during anti-androgen withdrawal predicts PSA flare after docetaxel chemotherapy in patients with castration-resistant prostate cancer.Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials.Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer.False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literatureLong-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.Changes in fPSA level could discriminate tPSA flare-up from tPSA progression in patients with castration-refractory prostate cancer during the initial phase of docetaxel-based chemotherapy.Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis.[Chemotherapy for prostate cancer].The efficacy and safety of docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration: JMTO Pca 10-01 phase II trial.Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare.What is behind the flare phenomenon?Q57135350
P2860
Q34141580-A155988F-8FF2-4395-83E1-9BE3868E6CB3Q35086041-7BF46E18-C8F5-4A37-B5E4-01BE50CE788CQ36045735-1CEA88D8-FB94-4DA3-B49D-44F56EEB9562Q37124741-9199038D-78C6-44E7-9B2A-73603045B128Q38703685-F54CD0BD-7A55-4D1D-B6C5-62DD7E84C8D7Q38827364-65A33EC7-2C1E-40AC-8B30-ECAD3D226235Q43704979-03569043-10D5-4699-B2DC-1B20DE4EB51CQ45738696-69C4704D-5501-4F3F-8978-02B6F98811C6Q46411737-48A1ACA0-2427-4B4C-BA2A-20415FF6204BQ50978342-92B452E3-033C-4B75-B5E7-3ED3296DAEC0Q53143774-A92C67A5-6C32-4D1F-B823-95833CE5C87AQ54516339-BA830BBA-35ED-4A6D-8621-DC4FB41C3817Q57135350-B92187D1-081B-47A6-8E01-362D75442027
P2860
Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Impact of PSA flare-up in pati ...... ancer undergoing chemotherapy.
@en
type
label
Impact of PSA flare-up in pati ...... ancer undergoing chemotherapy.
@en
prefLabel
Impact of PSA flare-up in pati ...... ancer undergoing chemotherapy.
@en
P2093
P1476
Impact of PSA flare-up in pati ...... cancer undergoing chemotherapy
@en
P2093
Thomas Nelius
Tobias Klatte
Werner de Riese
P304
P356
10.1007/S11255-007-9221-Y
P50
P577
2007-06-30T00:00:00Z